Slovak
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
International Journal of Cardiology 2018-Aug

Influence of BMI on inducible ventricular tachycardia and mortality in patients with myocardial infarction and left ventricular dysfunction: The obesity paradox.

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Odkaz sa uloží do schránky
Rahul Samanta
Jim Pouliopoulos
Saurabh Kumar
Arun Narayan
Fazlur Nadri
Pierre Qian
Stuart Thomas
Gopal Sivagangabalan
Pramesh Kovoor
Aravinda Thiagalingam

Kľúčové slová

Abstrakt

BACKGROUND

There is little known about the influence of obesity on ventricular electrical remodelling after myocardial infarction. The aim of our study was to assess the relationship between body mass index (BMI) and the primary outcome of inducible-VT and the secondary outcome of all-cause mortality in consecutive patients who presented with ST elevation myocardial infarction (STEMI) and LV-dysfunction (LVEF ≤ 40%).

RESULTS

Consecutive patients (n = 380) with STEMI and LV-dysfunction (LVEF ≤ 40%) underwent electrophysiological (EP) studies for risk-stratification. Inducible-VT ≥200 ms cycle-length (CL) with one to four extra-stimuli (ES) was considered abnormal. Patients were classified according their body mass index (BMI) to be normal (18.5-24.9), overweight (25-29.9) or obese (>30). The primary outcome of inducible-VT occurred in 42.7%, 21.5% and 21% of normal weight, overweight and obese patients respectively (p < 0.001). When adjusting for ejection-fraction, hypertension and triple-vessel-disease, normal BMI remained a significant predictor for inducible-VT. All-cause mortality was higher in patients with normal weight (12.8%) when compared to overweight (3.2%) and obese (3.8%) patients (p = 0.002) and was mainly driven by increased cardiac-death (6.8%, 1.9% and 1.9% in normal, overweight and obese patients respectively, p = 0.05). After adjusting for age, EF, and hypertension, normal BMI remained a significant predictor of mortality.

CONCLUSIONS

In patients presenting with STEMI and LV-dysfunction, BMI appears to be a significant predictor of inducible-VT and all-cause mortality, with worse outcomes for those with normal weight, when compared to overweight or obese individuals. These findings are consistent with the obesity-paradox.

Pripojte sa k našej
facebookovej stránke

Najkompletnejšia databáza liečivých bylín podporovaná vedou

  • Pracuje v 55 jazykoch
  • Bylinné lieky podporené vedou
  • Rozpoznávanie bylín podľa obrázka
  • Interaktívna GPS mapa - označte byliny na mieste (už čoskoro)
  • Prečítajte si vedecké publikácie týkajúce sa vášho hľadania
  • Vyhľadajte liečivé byliny podľa ich účinkov
  • Usporiadajte svoje záujmy a držte krok s novinkami, klinickými skúškami a patentmi

Zadajte príznak alebo chorobu a prečítajte si o bylinách, ktoré by vám mohli pomôcť, napíšte bylinu a pozrite sa na choroby a príznaky, proti ktorým sa používa.
* Všetky informácie sú založené na publikovanom vedeckom výskume

Google Play badgeApp Store badge